1. Home
  2. BGLC vs CHNR Comparison

BGLC vs CHNR Comparison

Compare BGLC & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • CHNR
  • Stock Information
  • Founded
  • BGLC N/A
  • CHNR N/A
  • Country
  • BGLC Malaysia
  • CHNR Hong Kong
  • Employees
  • BGLC 30
  • CHNR N/A
  • Industry
  • BGLC Medical Specialities
  • CHNR Precious Metals
  • Sector
  • BGLC Health Care
  • CHNR Basic Materials
  • Exchange
  • BGLC Nasdaq
  • CHNR Nasdaq
  • Market Cap
  • BGLC 9.2M
  • CHNR 8.6M
  • IPO Year
  • BGLC N/A
  • CHNR 1995
  • Fundamental
  • Price
  • BGLC $0.49
  • CHNR $0.77
  • Analyst Decision
  • BGLC
  • CHNR
  • Analyst Count
  • BGLC 0
  • CHNR 0
  • Target Price
  • BGLC N/A
  • CHNR N/A
  • AVG Volume (30 Days)
  • BGLC N/A
  • CHNR 713.0K
  • Earning Date
  • BGLC N/A
  • CHNR 05-16-2023
  • Dividend Yield
  • BGLC N/A
  • CHNR N/A
  • EPS Growth
  • BGLC N/A
  • CHNR N/A
  • EPS
  • BGLC N/A
  • CHNR N/A
  • Revenue
  • BGLC N/A
  • CHNR N/A
  • Revenue This Year
  • BGLC N/A
  • CHNR N/A
  • Revenue Next Year
  • BGLC N/A
  • CHNR N/A
  • P/E Ratio
  • BGLC N/A
  • CHNR N/A
  • Revenue Growth
  • BGLC N/A
  • CHNR N/A
  • 52 Week Low
  • BGLC N/A
  • CHNR $0.61
  • 52 Week High
  • BGLC N/A
  • CHNR $8.85
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 47.35
  • CHNR 45.69
  • Support Level
  • BGLC $0.46
  • CHNR $0.71
  • Resistance Level
  • BGLC $0.49
  • CHNR $0.82
  • Average True Range (ATR)
  • BGLC 0.02
  • CHNR 0.09
  • MACD
  • BGLC 0.00
  • CHNR 0.01
  • Stochastic Oscillator
  • BGLC 55.69
  • CHNR 30.00

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About CHNR China Natural Resources Inc.

China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.

Share on Social Networks: